OTC Markets OTCPK - Delayed Quote • USD Endonovo Therapeutics, Inc. (ENDV) Follow Compare 0.0002 0.0000 (0.00%) At close: February 12 at 3:51:29 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) -- Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement (APA), originally signed in December 2023, for the acquisition of Endonovo's assets and Intellectual Property (IP) for a minimum of $50 million. With completion of the APA, both Endonovo and SofPulse, Inc. share a strategic vision and a commitment for long term growth. Finalized Terms of SofPulse, Inc. Spi Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions US Army Medical Research and Development Command Vendor Day Los Angeles, CA, March 04, 2024 (GLOBE NEWSWIRE) -- SofPulse Inc. -- a subsidiary of Endonovo (OTC PINK: ENDV) and a proposed spin-off company -- announced today the participation of its SofPulse® Pulsed Electro-Magnetic Field (PEMF) FDA-cleared medical device in the United States Army Medical Research and Development Command (USAMRDC) May 2024 Vendor Day. The USAMRDC is the Army's medical materiel developer, responsible for medical res Performance Overview Trailing total returns as of 2/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return ENDV S&P 500 YTD -50.00% +2.90% 1-Year -95.12% +20.51% 3-Year -98.95% +36.96%